William McCombe

William McCombe

Chief Financial OfficeratCytek Biosciences· In proxies 2024–2025

Pay in FY2025+46% from the year before · Cytek Biosciences stock -22.2% the same year

William McCombe was paid $2.5M in FY2025 (Dec), up 46%. Cytek Biosciences stock fell 22.2% that year.

Pay$100 in the stock at the end of FY23 → $55
Pay is from the Summary Compensation Table of each Cytek Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cytek BiosciencesPublic company · 2 yr
    • Chief Financial Officer2024 – Present · 2 yrStock in role -35%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?